NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Virology


Reports from C. Smith et al highlight recent research in life sciences



NewsRx
Virology Library
Library Home

This article was published in Life Science Weekly, which you can subscribe to online.

NewsRx
NewsRx
2009 AUG 4 - (NewsRx.com) -- "Activation of the nuclear factor-kappa B pathway by Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) leads to an up-regulation of the major histocompatibility complex class I antigen-processing pathway. Paradoxically, LMP-1 itself induces a subdominant CD8(+) T-cell response and appears to have evolved to avoid immune recognition," scientists writing in the journal Blood report.

"Here we show that, although expression of LMP-1 in human cells dramatically enhanced the trans-presentation of CD8(+) T-cell epitopes, cis-presentation of LMP-1-derived epitopes was severely impaired. Testing of a series of LMP-1 mutants revealed that deletion of the first transmembrane domain of LMP-1, which prevented self-aggregation, significantly enhanced cis-presentation of T-cell epitopes from this protein, whereas it lost its ability to up-regulate trans-presentation. Interestingly, we also found that cis-presentation of LMP-1 epitopes was rescued by blocking the proteasome function," wrote C. Smith and colleagues.

The researchers concluded: "Taken together, these results delineate a novel mechanism of immune evasion, which renders a virally encoded oncogene inaccessible to the conventional major histocompatibility complex class I pathway limiting its cis-presentation to effector cells. (Blood. 2009; 113:6148-6152)."

Smith and colleagues published their study in Blood (Discerning regulation of cis- and trans-presentation of CD8(+) T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation. Blood, 2009;113(24):6148-6152).

Additional information can be obtained by contacting R. Khanna, Queensland Institute Med Research, Australian Center Vaccine Development & Tumour Immunology Laboratory, Division Immunology, 300 Herston Rd., Brisbane, Qld 4006, Australia.

The publisher of the journal Blood can be contacted at: American Society Hematology, 1900 M Street. NW Suite 200, Washington, DC 20036, USA.

Keywords: Australia, Brisbane, Life Sciences, EBV, Virology, Epstein-Barr Virus, Herpes, Herpesvirus, Chronic Fatigue Syndrome, Viral.

This article was prepared by Life Science Weekly editors from staff and other reports. Copyright 2009, Life Science Weekly via NewsRx.com.

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login